It was found that TNFα; (p < 0.0001) and (IL)-17A; (p = 0.038) increased serum concentration and decreased IL-10 protein concentration; (p = 0.024) in patients with MS, impairing the patients’ cognitive function [25]. This evidence concerns the gene IL10 and myeloid sarcoma.